Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 3

2(20.0%)

Phase 4

2(20.0%)

Phase 2

1(10.0%)

10Total

N/A(5)

Phase 3(2)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT01895933Not ApplicableCompleted

Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel

Role: collaborator

NCT02362633Not ApplicableCompleted

Effect of Long-term Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions

Role: lead

NCT02362607Not ApplicableCompleted

Integrated Diabetes Management Protocol Using Smartphone

Role: lead

NCT02362542Not ApplicableCompleted

Effect of Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions

Role: lead

NCT01658020Phase 3Completed

A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

Role: collaborator

NCT01903902Phase 4Unknown

Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries

Role: collaborator

NCT01645748Phase 2Completed

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

Role: collaborator

NCT01340118Phase 4Completed

Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of Asthma

Role: lead

NCT00893230Phase 3Completed

A Study of a Probiotic in Atopic Dermatitis

Role: lead

All 10 trials loaded